Journal: Biomolecules and Biomedicine
Article Title: ERBB4 as a therapeutic target in aortic dissection: Implications for cell-based therapies in vascular regeneration
doi: 10.17305/bb.2025.11925
Figure Lengend Snippet: Phenotype transition of VSMC cells. (A) IHC results revealed the decreased levels of α-actin, and TAGLN in aortic tissue; (B) Western blot results presented the decreased levels of α-actin, SPP1, TAGLN, and the highly expressed of epiregulin in aortic tissue. Bar graphs presented the quantification of α-actin (C), SPP1 (D), TAGLN (E), and epiregulin (F). vs Control group, ** P < 0.01, *** P < 0.001. VSMC: Vascular smooth muscle cell; IHC: Immunohistochemical; TAGLN: Transgelin.
Article Snippet: To prevent non-specific binding, membranes were blocked with 5% non-fat milk in Tris-buffered saline containing 0.1% Tween-20 (TBST) for 1 h at room temperature, followed by overnight incubation at 4 ∘ C with primary antibodies against ERBB4 (1:1000, Proteintech, Wuhan, China), α-actin (1:1000, Proteintech), Transgelin (TAGLN) (1:1000, Elabsience, Shanghai, China), SPP1 (1:1000, ZENBIO, Chengdu, China), epiregulin (1:1000, Biorbyt, UK), CD151 (1:1000, Proteintech), ITGAE (1:1000, ab224202, Abcam, UK), ITGB5 (1:1000, Proteintech), p-IκBα (1:5000, Proteintech), IκBα (1:5000, Proteintech), p-NF-κB-65 (1:2000, Proteintech), NF-κB-65 (1:1000, Proteintech), and GAPDH (1:50000, Proteintech) as a loading control.
Techniques: Western Blot, Control, Immunohistochemical staining